FACIOSCAPULOHUMERAL DYSTROPHY
Clinical trials for FACIOSCAPULOHUMERAL DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new FACIOSCAPULOHUMERAL DYSTROPHY trials appear
Sign up with your email to follow new studies for FACIOSCAPULOHUMERAL DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial hopes to slow muscle loss in FSHD
Disease control Recruiting nowThis study tests an experimental drug called AOC 1020 in 200 adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic disease that causes progressive muscle weakness. Participants receive either the drug or a placebo by IV every few weeks. The goal is to see if the dr…
Matched conditions: FACIOSCAPULOHUMERAL DYSTROPHY
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
New study aims to simplify walking assessments for rare muscle disease
Knowledge-focused Recruiting nowThis study looks at whether quick, easy walking tests can effectively measure mobility problems in adults with facioscapulohumeral muscular dystrophy (FSH), a genetic muscle disease that often causes walking difficulties. Researchers will compare these simple tests with the stand…
Matched conditions: FACIOSCAPULOHUMERAL DYSTROPHY
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated May 17, 2026 04:17 UTC